Skip to main content

Your search for “Clinical Trials” returned 692 results

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

November 21, 2022

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

UC San Diego Health Joins Precision Medicine Initiative to Tackle Pancreatic Cancer

October 4, 2016

…well as offering innovative clinical trials and the latest treatments with a personalized medicine approach. This expertise led to the selection of Moores Cancer Center as one of 12 clinical trial sites for the Pancreatic Cancer Action Network’s newly created Precision Promise, the first large-scale precision medicine trial network designed…

Study Uses Precision Medicine to Speed Drug Testing for Pancreatic Cancer

April 15, 2021

Moores Cancer Center at UC San Diego Health is among the few clinical trial sites in the U.S. for the Pancreatic Cancer Action Network’s (PanCAN) newly created Precision Promise, the first large-scale precision medicine trial designed to transform outcomes for patients with pancreatic cancer.

The Coming of Age of Stem Cell Therapy

October 30, 2014

…Diego Publications With first clinical trials, UC San Diego pushes stem cell therapies into a new era of real-world application In 2004, the therapeutic potential of stem cells persuaded more than 7 million Californians to approve Proposition 71, which allocated a whopping $3 billion for research and development of stem…

Novel Approaches to Treating Alzheimer’s Disease Include Early Intervention

May 15, 2012

Researchers at the Comprehensive Alzheimer’s Program at the University of California, San Diego School of Medicine have announced two new clinical trials for patients with either mild to moderate Alzheimer’s disease (AD) and one trial for Mild Cognitive Impairment.

Clinical Trial Evaluates Safety of Stem Cell Transplantation in Spine

August 11, 2014

Researchers at the University of California, San Diego School of Medicine have launched a clinical trial to investigate the safety of neural stem cell transplantation in patients with chronic spinal cord injuries. This Phase I clinical trial is recruiting eight patients for the 5-year study.

Researchers Expand Clinical Trials Investigating Convalescent Plasma Therapy for COVID-19

January 28, 2021

Researchers Expand Clinical Trials Investigating Convalescent Plasma Therapy for COVID-19 It’s hoped the long-used approach, which would use antibody-rich infusions, can either reduce disease symptoms or prevent infections after exposure to SARS-CoV-2 Parallel to COVID-19 vaccination efforts, physicians and researchers at UC San Diego Health, with collaborators across the country,…

UC San Diego Named Stem Cell “Alpha Clinic”

October 23, 2014

In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the California Institute for Regenerative Medicine, the state’s stem cell agency.

Stem Cell-Based Phase I Trial to Repair Spinal Cord Injuries Produces Encouraging Results

June 1, 2018

Researchers at University of California San Diego School of Medicine report that a first-in-human phase I clinical trial in which neural stem cells were transplanted into participants with chronic spinal cord injuries produced measurable improvement in three of four subjects, with no serious adverse effects.

UC San Diego Health Launches Clinical Trial to Assess Antiviral Drug for COVID-19

March 24, 2020

Researchers at four University of California Health medical centers have begun recruiting participants for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir, a drug that has shown promising activity against multiple viruses.

Category navigation with Social links